-
Bipartisan Funding Deal Reaches Senate Vote as Partial Shutdown Approaches; CMS Releases Final Rule on Medicaid Waiver of Uniform Tax Requirements
02 Feb 2026 21:43 GMT
… by the Supreme Court in Caraco v. Novo Nordisk. CRS … all dispensations of Lilly drugs, including in-house pharmacy drugs, drugs administered directly to … patients, and data from both pharmacy and medical …
-
Sun Pharma says talk of $10bn Organon bid is 'speculative'
19 Jan 2026 17:09 GMT
… development – suggested Sun Pharma wants to acquire Organon … medicines. Later, the newspaper put out another article acknowledging the pharma … Pharma since it took control of fellow Indian drugmaker … earlier bought generic drugmakers Caraco Pharma of the US and …
-
Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder
02 Dec 2025 12:57 GMT
… MEAI-based oral drug candidate, at Hadassah-University Medical Center in Jerusalem … Medical Center is led by Prof. Joseph Caraco, Director of the Clinical Pharmacology … Unit in the Department of Medicine …
-
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
13 Nov 2025 13:54 GMT
… , a proprietary MEAI-based oral drug candidate, for the treatment of … Medical Center will be led by Prof. Joseph Caraco, Director of Clinical Pharmacology … Unit in the Department of Medicine. Clearmind …
-
Clearmind Medicine (CMND) Stock Soars Thursday: What's Going On?
13 Nov 2025 18:47 GMT
… a proprietary MEAI-based oral drug candidate. Clearmind received final approval … Joseph Caraco, the director of the clinical pharmacology unit in the medical department … Pro. Operating in the pharmaceutical industry, Clearmind Medicine’s 52-week range …
-
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
19 Aug 2025 12:55 GMT
… ; August 19, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA … ;Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics … of Principal Investigator Prof. Yoseph Caraco, demonstrated a favorable safety and …
-
Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
05 Aug 2025 12:15 GMT
… , a proprietary MEAI-based oral drug candidate, for the treatment of … Medical Center will be led by Prof. Joseph Caraco, Director of Clinical Pharmacology … Unit in the Department of Medicine. IRB …
-
Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairman
13 Jun 2025 16:19 GMT
… succession planning process at Sun Pharma, underscoring the organisation’s … pursue his interests outside Sun Pharma, the statement says. Further, … , Caraco Pharmaceutical Laboratories facilitated entry into US2010: Launched first generic version cancer drug, …
-
Dilip Shanghvi has built Sun Pharma by making bold bets. And he's not done yet
30 Apr 2025 07:16 GMT
… about a new weight loss medicine that is showing promising … its first, acquiring US-based Caraco Pharmaceutical Laboratories to mark its entry into … areas beyond neuropsychiatry. “Sun Pharma started by launching neuropsychiatric drugs. Later, we entered …
-
<![CDATA[Skinny Labeling: Origins, Evolution, and Key Decisions]]>
08 Jan 2026 00:42 GMT
… regulatory strategy allowing generic drug manufacturers to omit patented … version of brand-name drugs without clarifying the excluded … the carved-out indication.
Caraco Pharmaceutical Labs v. Novo Nordisk …
Market or promote the drug in compliance with FDA …
About
© 1995-2026